Ed Martin, president of the Association of Racing Commissioners International, discusses concerns about increased federal involvement in regulating racing.
Racing industry officials said they again expect to see federal legislation filed this year that would authorize the United States Anti-Doping Agency to oversee equine medication and drug testing procedures.
No getting around the need for a national medication policy. read blog
The head of the United States Anti-Doping Agency Aug. 11 outlined how the organization could assist the Thoroughbred racing industry should its factions come together and push for federal legislation.
The Jockey Club Aug. 10 acknowledged progress on the effort to adopt uniform medication and drug-testing rules on a state-by-state basis, but also said it will advocate on the federal level for assistance.
The Association of Racing Commissioners International has released a state-by-state breakdown of the results of equine drug testing in 2013.
The chairman of The Jockey Club April 14 called for public release of the veterinary records of all horses entered in this year's Triple Crown races, and also said the industry should partner with USADA to push drug reform.
The president of horse racing's umbrella regulatory group said the tendency for self-flagellation and participants' refusal to take responsibility for their actions--or lack of action--is a major threat to the future.
The outgoing chairman of the Association of Racing Commissioners International said it is "vitally important" racing jurisdictions adopt the National Uniform Medication Program as soon as possible.
On March 28 Jockey Club chairman and owner/breeder Ogden Mills Phipps released a statement following allegations of horse abuse in racing raised by the People for Ethical Treatment of Animals.
In considering newest wrinkle to add federal oversight in horse racing, this time through the United States Anti-Doping Agency (USADA), a House subcommittee discussed the sport's equine health and integrity issues Nov. 21.
A diverse group of speakers will gather to discuss integrity and safety in horse racing at a U.S. House of Representatives subcommittee hearing scheduled for 10 a.m. Nov. 21 at the Rayburn House Office Building in Washington
- By Tom LaMarra
Whether members of Congress address legislation tied to medication and drug testing in horse racing remains to be seen, but the Thoroughbred industry appears to be more and more unwilling to take the chance it won't happen.
A U.S. Senator and four members of the House of Representatives have introduced the Horseracing Integrity and Safety Act of 2013 to regulate/prohibit substances, methods, and treatments that may be used in racing.
Travis T. Tygart, chief executive officer of the United States Anti-Doping Agency, will deliver the keynote address Aug. 12 at The Jockey Club's 60th Annual Round Table Conference.
By Barry Irwin -- Racing is at a crossroads on many fronts these days. The New York Racing Association has its back up against the wall. The National Thoroughbred Racing Association is in a leadership transition. The Thoroughbred Championship Tour is trying to get off the ground. Purses face erosion from off-shore betting schemes. But the single greatest problem facing the game--how to restore integrity to the race itself--is not receiving the attention it so desperately requires.
Most Popular Stories
- Mubtaahij Breezes Easy at Belmont Park
- American Pharoah Continues Churchill Training
- Stewart Pleased with Tale of Verve at Belmont
- Mikki Queen Rules in Japanese Oaks
- Main Sequence to Defend United Nations Title
- Pleascach Wins Irish One Thousand Guineas
- Medaglia d'Oro Colt Leads MM Weanling Session
- Looking for a Longshot in the Gamely Stakes
- American Pharoah Gallops Again at Churchill
- Frammento 'Developing Nicely' for Belmont